AstraZeneca drug cocktail succeeds in late-stage study to treat COVID-19

imageWorld47 minutes ago (Oct 11, 2021 03:40AM ET)

2/2
(C) Reuters. FILE PHOTO: The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, U.S., March 22, 2021. REUTERS/Rachel Wisniewski

2/2

(Reuters) -AstraZeneca’s experimental COVID-19 antibody drug cocktail succeeded in reducing severe disease or death in non-hospitalised patients in a late-stage study, the British drugmaker said on Monday.

The drug, called AZD7442, reduced the risk of developing severe COVID-19 or death by 50% in patients who had been symptomatic for seven days or less, meeting the main goal of the trial.

“An early intervention with our antibody can give a significant reduction in progression to severe disease, with continued protection for more than six months,” said Mene Pangalos, executive vice president, biopharmaceuticals R&D at AstraZeneca (NASDAQ:AZN).

The company will discuss the data with health authorities, it added, without elaborating.

AstraZeneca is also developing the drug cocktail as a therapy to protect people who do not have a strong enough immune response to COVID-19 vaccines. It requested emergency approval from U.S. regulators for its use as a prevention drug last week.

AstraZeneca drug cocktail succeeds in late-stage study to treat COVID-19

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Subscribe

Category

Related posts

Latest posts

U.S. FDA advisers back Pfizer/BioNTech COVID-19 vaccine for children

Stock Markets10 minutes ago (Oct 26, 2021 05:17PM ET) (C) Reuters. FILE PHOTO: A vial labelled with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine is seen...

U.S. Senate confirms Flake, McCain, Kennedy, Udall as ambassadors

Politics11 minutes ago (Oct 26, 2021 05:17PM ET) 2/2 (C) Reuters. FILE PHOTO: Sen. Tom Udall, D-N.M., speaks during a Senate Foreign Relations Committee hearing on...

Oil Inventories Rose by 2.3M Barrels Last Week: API

Sign In/Free Sign Up 0 Commodities35 minutes ago (Oct 26, 2021 04:52PM ET) (C) Reuters. By Yasin Ebrahim Investing.com - U.S. crude stockpiles rose more...